Traws Pharma, Inc.
Ticker: 1130598
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 | Q2 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 2.73+4450.0% | 0.06+0.0% | 0.06+0.0% | 0.06+0.0% | 0.06+0.0% | 0.06+0.0% | 0.06+0.0% | 0.06 |
| Total Income | 2.73+4450.0% | 0.06+0.0% | 0.06+0.0% | 0.06+0.0% | 0.06+0.0% | 0.06+0.0% | 0.06+0.0% | 0.06 |
| EXPENSES | ||||||||
| Expenditure | 3.98-24.3% | 5.26-38.8% | 8.59+0.0% | 8.59-93.0% | 123.41+2241.7% | 5.27+2.3% | 5.15+10.3% | 4.67 |
| PROFIT | ||||||||
| Net Profit | -0.92-104.3% | 21.49+353.4% | -8.48+0.0% | -8.48+93.1% | -123.14-2372.7% | -4.98-5.1% | -4.74-11.5% | -4.25 |
| KEY METRICS | ||||||||
| OPM % | -45.70%+54.30pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -33.48%-133.48pp | 100.00%+200.00pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.11-105.1% | 2.17+124.6% | -8.81-491.3% | -1.49+69.4% | -4.87-1929.2% | -0.24-4.3% | -0.23-15.0% | -0.20 |
Corporate Events
Board MeetingTRAW
20268Jul
Board Meeting
Annual Meeting of Stockholders to elect directors, approve a…
SEC Filing ↗